Find Alteplase manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

API Suppliers

API Suppliers

0

USDMF

US DMFs Filed

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

VMF

NDC API

0

Listed Suppliers

Other Suppliers

API REF. PRICE (USD/KG)

$
$ 0

MARKET PLACE

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

Australia

Australia

0

Listed Dossiers

Listed Dossiers

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

GLOBAL SALES INFORMATION

US Medicaid

NA

Finished Drug Prices

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 177799-16-5, Ttpa, 9,10-bis[n,n-di(p-tolyl)amino]anthracene, 9-n,9-n,10-n,10-n-tetrakis(4-methylphenyl)anthracene-9,10-diamine, N9,n9,n10,n10-tetra-p-tolylanthracene-9,10-diamine, Schembl1261345
Molecular Formula
C42H36N2
Molecular Weight
568.7  g/mol
InChI Key
FWXNJWAXBVMBGL-UHFFFAOYSA-N

Alteplase
A proteolytic enzyme in the serine protease family found in many tissues which converts PLASMINOGEN to FIBRINOLYSIN. It has fibrin-binding activity and is immunologically different from UROKINASE-TYPE PLASMINOGEN ACTIVATOR. The primary sequence, composed of 527 amino acids, is identical in both the naturally occurring and synthetic proteases.
1 2D Structure

Alteplase

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
9-N,9-N,10-N,10-N-tetrakis(4-methylphenyl)anthracene-9,10-diamine
2.1.2 InChI
InChI=1S/C42H36N2/c1-29-13-21-33(22-14-29)43(34-23-15-30(2)16-24-34)41-37-9-5-7-11-39(37)42(40-12-8-6-10-38(40)41)44(35-25-17-31(3)18-26-35)36-27-19-32(4)20-28-36/h5-28H,1-4H3
2.1.3 InChI Key
FWXNJWAXBVMBGL-UHFFFAOYSA-N
2.1.4 Canonical SMILES
CC1=CC=C(C=C1)N(C2=CC=C(C=C2)C)C3=C4C=CC=CC4=C(C5=CC=CC=C53)N(C6=CC=C(C=C6)C)C7=CC=C(C=C7)C
2.2 Synonyms
2.2.1 MeSH Synonyms

1. Actilyse

2. Activase

3. Alteplase

4. Lysatec Rt Pa

5. Lysatec Rt-pa

6. Lysatec Rtpa

7. Plasminogen Activator, Tissue

8. Plasminogen Activator, Tissue Type

9. Plasminogen Activator, Tissue-type

10. T Plasminogen Activator

11. T-plasminogen Activator

12. Tisokinase

13. Tissue Activator D 44

14. Tissue Activator D-44

15. Tissue Plasminogen Activator

16. Tissue Type Plasminogen Activator

17. Tissue-type Plasminogen Activator

18. Ttpa

2.2.2 Depositor-Supplied Synonyms

1. 177799-16-5

2. Ttpa

3. 9,10-bis[n,n-di(p-tolyl)amino]anthracene

4. 9-n,9-n,10-n,10-n-tetrakis(4-methylphenyl)anthracene-9,10-diamine

5. N9,n9,n10,n10-tetra-p-tolylanthracene-9,10-diamine

6. Schembl1261345

7. Dtxsid30629288

8. Cha79916

9. 9,10-anthracenediamine, N9,n9,n10,n10-tetrakis(4-methylphenyl)-

10. Mfcd12022465

11. Akos027252460

12. As-71559

13. 9,10-bis[n,n-di(p-tolyl)amino]anthracene, 98%

14. N,n,n',n'-tetrakis(p-tolyl)anthracene-9,10-diamine

15. N,n,n',n'-tetrakis(4-methylphenyl)-9,10-anthracenediamine

16. N~9~,n~9~,n~10~,n~10~-tetrakis(4-methylphenyl)anthracene-9,10-diamine

17. N9,n9,n10,n10-tetrakis(4-methylphenyl)anthracene-9,10-diamine

2.3 Create Date
2007-12-05
3 Chemical and Physical Properties
Molecular Weight 568.7 g/mol
Molecular Formula C42H36N2
XLogP312.4
Hydrogen Bond Donor Count0
Hydrogen Bond Acceptor Count2
Rotatable Bond Count6
Exact Mass568.287849157 g/mol
Monoisotopic Mass568.287849157 g/mol
Topological Polar Surface Area6.5 Ų
Heavy Atom Count44
Formal Charge0
Complexity728
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Pharmacology and Biochemistry
4.1 MeSH Pharmacological Classification

Fibrinolytic Agents

Fibrinolysin or agents that convert plasminogen to FIBRINOLYSIN. (See all compounds classified as Fibrinolytic Agents.)


Europe

read-more
read-more

01

euroPLX 86 Munich
Not Confirmed
arrow
arrow
euroPLX 86 Munich
Not Confirmed

alteplase

Brand Name : Actilyse

Dosage Form : POWDER AND SOLVENT FOR SOLUTION FOR INJECTION

Dosage Strength : -

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank

02

euroPLX 86 Munich
Not Confirmed
arrow
arrow
euroPLX 86 Munich
Not Confirmed

Alteplase

Brand Name : Actilyse

Dosage Form : POWDER AND SOLVENT FOR SOLUTION FOR INJECTION

Dosage Strength : -

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank

03

Orifarm AB

Denmark
euroPLX 86 Munich
Not Confirmed
arrow

Orifarm AB

Denmark
arrow
euroPLX 86 Munich
Not Confirmed

alteplase

Brand Name : Actilyse

Dosage Form : POWDER AND SOLVENT FOR SOLUTION FOR INJECTION

Dosage Strength : -

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank

04

Orifarm AB

Denmark
euroPLX 86 Munich
Not Confirmed
arrow

Orifarm AB

Denmark
arrow
euroPLX 86 Munich
Not Confirmed

alteplase

Brand Name : Actilyse

Dosage Form : POWDER AND SOLVENT FOR SOLUTION FOR INJECTION

Dosage Strength : -

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank

05

Orifarm AB

Denmark
euroPLX 86 Munich
Not Confirmed
arrow

Orifarm AB

Denmark
arrow
euroPLX 86 Munich
Not Confirmed

alteplase

Brand Name : Actilyse

Dosage Form : POWDER AND SOLVENT FOR SOLUTION FOR INJECTION

Dosage Strength : -

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank

06

euroPLX 86 Munich
Not Confirmed
arrow
arrow
euroPLX 86 Munich
Not Confirmed

Alteplase

Brand Name : Actilyse

Dosage Form :

Dosage Strength :

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank

07

euroPLX 86 Munich
Not Confirmed
arrow
arrow
euroPLX 86 Munich
Not Confirmed

alteplase

Brand Name : Actilyse

Dosage Form : POWDER AND SOLVENT FOR SOLUTION FOR INJECTION

Dosage Strength : -

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank

08

euroPLX 86 Munich
Not Confirmed
arrow
arrow
euroPLX 86 Munich
Not Confirmed

alteplase

Brand Name : Actilyse

Dosage Form : POWDER AND SOLVENT FOR SOLUTION FOR INJECTION

Dosage Strength : -

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank

09

Pharmachim AB

Country
euroPLX 86 Munich
Not Confirmed
arrow

Pharmachim AB

Country
arrow
euroPLX 86 Munich
Not Confirmed

alteplase

Brand Name : Actilyse

Dosage Form : POWDER AND SOLVENT FOR SOLUTION FOR INJECTION

Dosage Strength : -

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank

10

Pharmachim AB

Country
euroPLX 86 Munich
Not Confirmed
arrow

Pharmachim AB

Country
arrow
euroPLX 86 Munich
Not Confirmed

alteplase

Brand Name : Actilyse

Dosage Form : POWDER AND SOLVENT FOR SOLUTION FOR INJECTION

Dosage Strength : -

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Digital Content read-more

Create Content with PharmaCompass, ask us

DATA COMPILATION #PharmaFlow

read-more
read-more

NEWS #PharmaBuzz

read-more
read-more

Global Sales Information

Do you need Business Intel? Ask us

Market Place

Do you need sourcing support? Ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty